ArticleDiseases (Basel, Switzerland)2026
Report on Successful Treatment of Refractory MAC 2 Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.
Kenjiro Nagai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.